Genomictree Inc. Financial Flexibility Index
Genomictree Inc. financial flexibility index. Genomictree Inc. (228760) has a Financial Flexibility Index of -0.58x as of December 2025. Free cash flow of ₩-3.15 Billion (operating CF ₩-3.21 Billion minus capex ₩62.29 Million) represents -1% of total liabilities (₩5.45 Billion). See 228760 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Genomictree Inc. (2020–2025)
Financial flexibility index of Genomictree Inc. from 2020 to 2025. Historical Financial Flexibility Index trend for Genomictree Inc. across 6 annual periods. Explore 228760 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Genomictree Inc. Financial Flexibility Index by Year (2020–2025)
Genomictree Inc. financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Genomictree Inc.. For the full cash flow conversion analysis, see Genomictree Inc. cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.37x | ₩-7.45 Billion | ₩-10.19 Billion | ₩5.45 Billion | ▲ +21.7% |
| 2024 | -1.74x | ₩-11.08 Billion | ₩-13.63 Billion | ₩6.36 Billion | ▼ -28.6% |
| 2023 | -1.36x | ₩-10.59 Billion | ₩-10.88 Billion | ₩7.81 Billion | ▼ -1339.5% |
| 2022 | 0.11x | ₩6.11 Billion | ₩4.29 Billion | ₩55.86 Billion | ▲ +61.7% |
| 2021 | 0.07x | ₩4.20 Billion | ₩-7.63 Billion | ₩62.05 Billion | ▲ +120.4% |
| 2020 | -0.33x | ₩-7.50 Billion | ₩-10.19 Billion | ₩22.64 Billion | — |